The analysis of clinical characteristics of HNSCC patients and FAT1 mutations unveiled significant associations between FAT1 mutations and patients’ age, ranging from 40 to 90 years, as well as the M stage (Figure 1C). This evidence concerns the gene FAT1 and head and neck squamous cell carcinoma.